Elevate Capital Advisors, LLC Roivant Sciences Ltd. Transaction History
Elevate Capital Advisors, LLC
- $151 Billion
- Q4 2025
A detailed history of Elevate Capital Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Elevate Capital Advisors, LLC holds 77,545 shares of ROIV stock, worth $1.57 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
77,545
Previous 113,781
31.85%
Holding current value
$1.57 Million
Previous $1.72 Billion
2.25%
% of portfolio
1.11%
Previous 1.2%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
400Shares Held
466MCall Options Held
6.03MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA42.1MShares$853 Million0.01% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...